📣 Join us at the Obesity Medicine 2026 Conference • April 10-12 • Booth #201
Details
MyPhenome
Contact
📣 Join us at the Obesity Medicine 2026 Conference • April 10-12 • Booth #201
Platform
Evidence
Partners
Providers
Patients
Company
Our story
Meet the team
Media & press
MyPhenome
Contact
Media & press
Latest
Article
TIME Magazine: A New Test Predicts Who Will Benefit Most From Weight-Loss Drugs
TIME Magazine
-
-
May 20, 2024
-
Alice Park
-
As popular as the new group of weight-loss drugs like Wegovy and Zepbound are, not everyone responds the same way.
Read article
All
Article
Podcast
Press Release
Webinar
Podcast
Why Do a Significant Number of GLP-1 Users Stop Taking the Medication in the First Year?
PharmaExec
-
-
April 6, 2026
-
Mike Hollan, Mark Bagnall
Phenomix CEO Mark Bagnall discusses the reasons for GLP-1 failure and why it’s common for patients to stop taking the medication.
Read article
Listen
Podcast
"Can a test tell me if Wegovy or Zepbound will work for me?" with Dr. Andres Acosta
-
-
September 8, 2025
-
The Dr. Francavilla Show
How genetic insights are reshaping weight loss strategies—moving beyond trial-and-error toward precision-guided interventions.
Read article
Listen
Podcast
Precision Medicine for Weight Loss: Dr. Andres Acosta
Practically Healthy
-
-
November 6, 2024
-
Dr. Melina
Dr Melina welcomes world renowned gastroenterologist and obesity expert Andres J. Acosta, M.D., Ph.D.
Read article
Listen
Podcast
What Is Your Obesity Type? This Could Change Everything, with Dr. Andres Acosta
-
-
July 4, 2024
-
In this episode of Causes or Cures, Dr. Eeks chats with Dr. Andres Acosta MD PHD about the identification of 4 phenotypes for obesity and how they can revolutionize the future of obesity treatment.
Read article
Listen
Podcast
The Problem with Ozempic
Dr. Karan Explores - Podcast
-
-
June 14, 2024
-
Dr. Karan Rajan
“Ozempic has changed the conversation around obesity. Unfortunately a lot of people are misusing the medication.” -Dr Andres Acosta
Read article
Listen
